Literature DB >> 11471037

Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage: comparative study with a postmortem lung biopsy.

A B Balthazar1, A Von Nowakonski, E M De Capitani, P V Bottini, R G Terzi, S Araújo.   

Abstract

The purpose of the present study was to validate the quantitative culture and cellularity of bronchoalveolar lavage (BAL) for the diagnosis of ventilator-associated pneumonia (VAP). A prospective validation test trial was carried out between 1992 and 1997 in a general adult intensive care unit of a teaching hospital. Thirty-seven patients on mechanical ventilation with suspected VAP who died at most three days after a BAL diagnostic procedure were submitted to a postmortem lung biopsy. BAL effluent was submitted to Gram staining, quantitative culture and cellularity count. Postmortem lung tissue quantitative culture and histopathological findings were considered to be the gold standard exams for VAP diagnosis. According to these criteria, 20 patients (54%) were diagnosed as having VAP and 17 (46%) as not having the condition. Quantitative culture of BAL effluent showed 90% sensitivity (18/20), 94.1% specificity (16/17), 94.7% positive predictive value and 88.8% negative predictive value. Fever and leukocytosis were useless for VAP diagnosis. Gram staining of BAL effluent was negative in 94.1% of the patients without VAP (16/17). Regarding the total cellularity of BAL, a cut-off point of 400,000 cells/ml showed a specificity of 94.1% (16/17), and a cut-off point of 50% of BAL neutrophils showed a sensitivity of 90% (19/20). In conclusion, BAL quantitative culture, Gram staining and cellularity might be useful in the diagnostic investigation of VAP.

Entities:  

Mesh:

Year:  2001        PMID: 11471037     DOI: 10.1590/s0100-879x2001000800004

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  11 in total

1.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

2.  Outcome of ventilator-associated pneumonia: Impact of antibiotic therapy and other factors.

Authors:  Noyal Mariya Joseph; Sujatha Sistla; Tarun Kumar Dutta; Ashok Shankar Badhe; Desdemona Rasitha; Subhash Chandra Parija
Journal:  Australas Med J       Date:  2012-02-29

3.  Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia.

Authors:  James M Walter; Ziyou Ren; Tyrone Yacoub; Paul A Reyfman; Raj D Shah; Hiam Abdala-Valencia; Kiwon Nam; Vince K Morgan; Kishore R Anekalla; Nikita Joshi; Alexandra C McQuattie-Pimentel; Ching-I Chen; Monica Chi; SeungHye Han; Francisco J Gonzalez-Gonzalez; Saul Soberanes; Raul P Aillon; Satoshi Watanabe; Kinola J N Williams; Ziyan Lu; Joseph Paonessa; Peter Hountras; Madonna Breganio; Nicole Borkowski; Helen K Donnelly; Jonathan P Allen; Luis A Amaral; Ankit Bharat; Alexander V Misharin; Neda Bagheri; Alan R Hauser; G R Scott Budinger; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

4.  Comparison of bronchoscopic and non-bronchoscopic techniques for diagnosis of ventilator associated pneumonia.

Authors:  G C Khilnani; T K Luqman Arafath; Vijay Hadda; Arti Kapil; Seema Sood; S K Sharma
Journal:  Indian J Crit Care Med       Date:  2011-01

5.  Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation.

Authors:  Michael Klompas; Yosef Khan; Kenneth Kleinman; R Scott Evans; James F Lloyd; Kurt Stevenson; Matthew Samore; Richard Platt
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

6.  Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia.

Authors:  Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Sanvicente; Juliana Sartori; Elyara Fiorin Pacheco
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

7.  Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients.

Authors:  Pouline M P van Oort; Sanne de Bruin; Hans Weda; Hugo H Knobel; Marcus J Schultz; Lieuwe D Bos
Journal:  Int J Mol Sci       Date:  2017-02-19       Impact factor: 5.923

8.  Ex Vivo Evaluation of Secretion-Clearing Device in Reducing Airway Resistance within Endotracheal Tubes.

Authors:  Christopher Waters; R Constance Wiener; Hamed M Motlagh
Journal:  Crit Care Res Pract       Date:  2018-12-10

Review 9.  Diagnosis of ventilator-associated pneumonia: a systematic review of the literature.

Authors:  Alvaro Rea-Neto; Nazah Cherif M Youssef; Fabio Tuche; Frank Brunkhorst; V Marco Ranieri; Konrad Reinhart; Yasser Sakr
Journal:  Crit Care       Date:  2008-04-21       Impact factor: 9.097

10.  Comparison of Blind Endotracheal Aspiration and Bronchoscopic Brush Biopsy Sampling Methods for Bacteriological Diagnosis of Ventilator-Associated Pneumonia in Intensive Care Unit.

Authors:  Jyoti Gupta; Vijay Kumar Nagpal; Mohandeep Kaur; Jyoti Sharma; Ajay K Goila; Neha Kathor
Journal:  Anesth Essays Res       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.